The revision of CPT 29826 from a standalone code to an add-on code — +29826 (Arthroscopy, shoulder, surgical; decompression of subacromial space with partial acromioplasty, with coracoacromial ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Published results showed patients with shoulder ...
Please provide your email address to receive an email when new articles are posted on . Durect Corporation has announced the FDA approval of Posimir, a post-surgical, non-opioid local analgesic for ...
Objectives To assess the long-term efficacy of arthroscopic subacromial decompression (ASD) by comparing it with diagnostic arthroscopy (primary comparison), a placebo surgical intervention, and with ...
Objective To determine the benefits and harms of subacromial decompression surgery in adult patients with subacromial pain syndrome lasting for more than 3 months. Design Systematic review with ...
POSIMIR ® (bupivacaine solution) for infiltration use reduced mean pain over 72 hours after arthroscopic subacromial decompression surgery compared with vehicle control and improved several measures ...
Subacromial pain syndrome refers to non-traumatic pain, weakness or loss of movement around the shoulder, particularly when lifting the arm. It is common in people over 40 years old and decompression ...
CUPERTINO, Calif., Feb. 2, 2021 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration (FDA) has approved POSIMIR® (bupivacaine solution) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback